Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025641 | 12602564 | 1 | I | 20160330 | 20160719 | 20160728 | 20160728 | EXP | NL-LRB-222414 | NL-NOVOPROD-501930 | NOVO NORDISK | 70.00 | YR | E | M | Y | 113.00000 | KG | 20160728 | MD | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025641 | 12602564 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | UNK | Y | U | UNKNOWN | 22341 | SOLUTION FOR INJECTION | ||||||
| 126025641 | 12602564 | 2 | C | OXYCODONE | OXYCODONE | 1 | Oral | 20 MG, BID | UNKNOWN | 0 | 20 | MG | TABLET | BID | |||||
| 126025641 | 12602564 | 3 | C | MESALAZINE | MESALAMINE | 1 | Rectal | 500 MG, TID | UNKNOWN | 0 | 500 | MG | SUPPOSITORY | TID | |||||
| 126025641 | 12602564 | 4 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, QD | UNKNOWN | 0 | 20 | MG | QD | ||||||
| 126025641 | 12602564 | 5 | C | CEDAX | CEFTIBUTEN DIHYDRATE | 1 | Oral | 400 MG, QD | UNKNOWN | 0 | 400 | MG | TABLET | QD | |||||
| 126025641 | 12602564 | 6 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 50 MG, BID | UNKNOWN | 0 | 50 | MG | CAPSULE | BID | |||||
| 126025641 | 12602564 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | UNKNOWN | 0 | 500 | MG | TABLET | BID | |||||
| 126025641 | 12602564 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, BID | UNKNOWN | 0 | 20 | MG | CAPSULE | BID | |||||
| 126025641 | 12602564 | 9 | C | ASCAL /00002702/ | ASPIRIN CALCIUM | 1 | Oral | 100 MG, QD | UNKNOWN | 0 | 100 | MG | TABLET | QD | |||||
| 126025641 | 12602564 | 10 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 10 MG, BID | UNKNOWN | 0 | 10 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126025641 | 12602564 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126025641 | 12602564 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126025641 | 12602564 | Abdominal pain lower | |
| 126025641 | 12602564 | Decreased appetite | |
| 126025641 | 12602564 | Liver function test abnormal | |
| 126025641 | 12602564 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126025641 | 12602564 | 1 | 20160211 | 20160710 | 0 |